GB792978A - Improvements in or relating to streptomycin salts - Google Patents
Improvements in or relating to streptomycin saltsInfo
- Publication number
- GB792978A GB792978A GB1776/56A GB177656A GB792978A GB 792978 A GB792978 A GB 792978A GB 1776/56 A GB1776/56 A GB 1776/56A GB 177656 A GB177656 A GB 177656A GB 792978 A GB792978 A GB 792978A
- Authority
- GB
- United Kingdom
- Prior art keywords
- streptomycin
- salt
- inositol
- phytate
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
Abstract
The invention relates to a salt of streptomycin and a phosphorylated inositol, especially one containing three molecules of streptomycin per molecule of phytic acid. The salt may be hydrated or anhydrous. Where free acid groups are available for further salt formation, non-toxic metal ions such as sodium, potassium, ammonium, calcium and magnesium may be present. The phytic acid (inositol hexaphosphoric acid) may be replaced by other inositol phosphoric acids such as the tri- and tetraphosphoric acid. It is preferred to react a water-soluble phytate, e.g. sodium phytate, with a water-soluble salt of streptomycin, e.g. streptomycin sulphate, in aqueous solution at a pH of 7 to 8, preferably after a preliminary treatment with carbon. Streptomycin phytate is therapeutically active, non-toxic and relatively insoluble in water. It is used medicinally (see Group VI) and in the recovery of streptomycin from aqueous solution.ALSO:A therapeutic preparation in the form of a powder, tablet, capsule or aqueous or oily suspension for oral or parenteral use, comprises a salt of streptomycin and a phosphorylated inositol, e.g. streptomycin phytate (see Group IV (b)) with or without the addition of other medicaments. An edible oil such as coconut oil or an injectable oil such as peanut oil, as such or gelled with aluminium monostearate, forms the vehicle for the oily suspensions. Optional ingredients are (a) suspending agents such as sodium carboxymethyl cellulose, methyl cellulose, polyvinyl alcohol, polyvinyl pyrrolidone, gum tragacanth, gelatine, pectin, alginates, dextrans, gum karaya, lecithin, polyoxyalkylene derivatives, glyceryl monostearate, inositol phosphoric acids and their non-toxic salts; (b) buffers such as sodium citrate or sodium phosphate; (c) preservatives, e.g. phenol, cresol, alkyl esters of p-hydroxy benzoic acid; (d) other pharmaceutical adjuvants. The particle size of the streptomycin phylate may be varied. Specified other medicaments are anti-histamines, sulpha drugs, vitamins, lipotropic agents, stimulants, analgesics, laxatives, sedatives and antibiotics such as potassium benzyl penicillin. The streptomycin phylate particles may be coated with a suspending agent such as lecithin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1776/56A GB792978A (en) | 1956-01-18 | 1956-01-18 | Improvements in or relating to streptomycin salts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1776/56A GB792978A (en) | 1956-01-18 | 1956-01-18 | Improvements in or relating to streptomycin salts |
Publications (1)
Publication Number | Publication Date |
---|---|
GB792978A true GB792978A (en) | 1958-04-09 |
Family
ID=9727788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1776/56A Expired GB792978A (en) | 1956-01-18 | 1956-01-18 | Improvements in or relating to streptomycin salts |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB792978A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6278004B1 (en) | 1996-11-06 | 2001-08-21 | Aventis Pharma Deutschland Gmbh | Stabilized phospholipidic composition |
-
1956
- 1956-01-18 GB GB1776/56A patent/GB792978A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6278004B1 (en) | 1996-11-06 | 2001-08-21 | Aventis Pharma Deutschland Gmbh | Stabilized phospholipidic composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1108622A (en) | Metronidazole phosphate and salts | |
EP0183527B1 (en) | Absorbable calcitonin medicament | |
EP0216459A1 (en) | 9-Substituted guanine monohydrates | |
JPS61151125A (en) | Dihydrocodeine/ibuprofen drug composition and method | |
GB1378348A (en) | Orally administered drug composition for therapy in the treatment of narcotic drug addiction | |
JPS5946947B2 (en) | (+) Catechin salt | |
IE39281B1 (en) | Compisitions for radiographic scanning | |
US2791609A (en) | Tetracycline metallo-phosphate complexes and method preparation | |
US2795528A (en) | Therapeutic composition containing a tetracycline and a phosphate other than orthophosphate | |
IE903717A1 (en) | S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics | |
EP0145209B1 (en) | A kit or device and method for administering gangliosides and derivatives thereof of inhalation and pharmaceutical compositions suitable therefor | |
JPH09110700A (en) | Medicinal composition | |
US2816059A (en) | N-[beta-(o-chlorophenyl)-beta-(hydroxy)-ethyl] isopropyl amine, salts thereof, and compositions containing same | |
ES460098A1 (en) | Derivatives of penicillanic acid | |
GB792978A (en) | Improvements in or relating to streptomycin salts | |
JPS5817167B2 (en) | Pharmaceutical composition with antiviral action | |
CN105884827B (en) | Pyrimidine amide derivatives and its salt | |
PT86644B (en) | Process for the preparation of dry formulations containing a diclofenac salt | |
US2710860A (en) | Nikethamide adenylate | |
JPH08295637A (en) | Local administrative agent for oral cavity | |
US3697563A (en) | (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders | |
KR890002128A (en) | Soluble derivatives of silvibin, methods for their preparation and pharmaceutical compositions containing them | |
EP0030023A3 (en) | A heterocyclic compound and its synthesis, pharmaceutical formulations thereof and the use of the compounds and the formulations in medicine | |
US3755599A (en) | Methods for relieving bronchospasm with prostaglandin a compounds | |
US3965167A (en) | Crystalline ammonium N-acetyl-L-cysteinate and mucolytic process |